Capricor Therapeutics (NASDAQ: CAPR) shares fell about 13% to $8.30 on Monday, extending their losing streak to three sessions. The decline preceded an after-hours...
Charles Hoskinson confirms a December 15 Midnight presentation, promising surprise announcements and a preview of the blockchain's 2027 plans.
Cardano...